Lonza Completes Clinical and Commercial Drug Product Manufacturing Line in Visp (CH)
Lonza increases capacity and capabilities in Visp (CH) with the completion of a new line for cGMP clinical and commercia…
Lonza increases capacity and capabilities in Visp (CH) with the completion of a new line for cGMP clinical and commercia…
. Lonza will invest to expand its drug product manufacturing network in Switzerland The investment will include instal…
IDT Biologika is developing a vaccine against respiratory syncytial virus (RSV) for the National Institute of Allergy an…
Lonza is holding a series of events as part of this year's Capital Markets Day from 24-26 September in Zurich and Visp (…
Supplying drugs that must be administered as a liquid in solid form has been an approach used to improve drug stability…
Arte Corporation and ProJect Pharmaceutics have been working closely on the development of a new type of dual chamber pr…
The agreement grants DSM rights to c-LEcta's proprietary alcohol dehydrogenases for enzyme screening programs and develo…
Unique 1064nm Raman Spectrometer resolves fluorescence issues seen at lower wavelengths : While algal oil is similar to…